Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

O&G TopicsAntenatal care — maternal medicine

O&G · Antenatal care — maternal medicine

Gestational diabetes: screening, diagnosis, management

Also known as GDM · Gestational diabetes mellitus · Hyperglycaemia in pregnancy · Glucose intolerance of pregnancy · Pregnancy oral glucose tolerance test · POGTT

Exam-exhaustive FRANZCOG fellowship reference on gestational diabetes — the ADIPS 2025 diagnostic thresholds and the screening controversy behind them, HAPO, GEMS, TARGET, TOBOGM and ScreenR2GDM, medical nutrition therapy, metformin and insulin with doses, fetal surveillance, timing and mode of birth, intrapartum glycaemic control, neonatal hypoglycaemia and the postpartum OGTT. RANZCOG-primary, globally tagged to MRCOG and ABOG.

high20 referencesUpdated 26 July 202617 min readVerification in progress

Your progress

Saved on this device.

Target exams

FRANZCOGMRCOGABOGFRCSCMRCPI

Red flags

  • First-trimester HbA1c at or above 6.5 percent (48 mmol/mol) — that is overt diabetes in pregnancy, not GDM, and it changes everything you do
  • Ketones in a woman labelled with GDM — think undiagnosed type 1 diabetes and exclude ketoacidosis before you reach for the diet sheet
  • Accelerating abdominal circumference on serial growth scans despite in-range diaries — believe the fetus, not the logbook
  • A GDM diagnosis with no dietitian, no interpreter and no glucose strips is a label, not a treatment
  • Polyhydramnios with a large-for-dates fetus — re-test glucose even if the 24–28 week POGTT was normal
  • The forgotten postpartum oral glucose tolerance test — one in ten of these women already has type 2 diabetes
On this page
Study tools

Your progress

Saved on this device.

Target exams

FRANZCOGMRCOGABOGFRCSCMRCPI

Red flags

  • First-trimester HbA1c at or above 6.5 percent (48 mmol/mol) — that is overt diabetes in pregnancy, not GDM, and it changes everything you do
  • Ketones in a woman labelled with GDM — think undiagnosed type 1 diabetes and exclude ketoacidosis before you reach for the diet sheet
  • Accelerating abdominal circumference on serial growth scans despite in-range diaries — believe the fetus, not the logbook
  • A GDM diagnosis with no dietitian, no interpreter and no glucose strips is a label, not a treatment
  • Polyhydramnios with a large-for-dates fetus — re-test glucose even if the 24–28 week POGTT was normal
  • The forgotten postpartum oral glucose tolerance test — one in ten of these women already has type 2 diabetes
One-line fellowship answer

Gestational diabetes is hyperglycaemia first detected in pregnancy that falls short of overt diabetes — in Australia and Aotearoa New Zealand you diagnose it on a 75 g two-hour pregnancy OGTT at fasting 5.3 mmol/L or more, one hour 10.6 mmol/L or more, or two hours 9.0 mmol/L or more (ADIPS 2025), treat with nutrition therapy first and metformin or insulin when the diary misses target, plan birth by around 40+6 weeks (earlier if insulin-treated or macrosomic), keep intrapartum glucose 4–7 mmol/L, expect neonatal hypoglycaemia, and book the postpartum oral glucose tolerance test before she leaves.[1][8][14]

It is Tuesday clinic and the GP has sent a 33-year-old at 26 weeks with a fasting glucose of 5.4 mmol/L. Two years ago that number was normal; today it is a diagnosis. Nothing about her has changed — the threshold has. That single sentence is the whole examinable tension in this topic, and the candidate who can argue it from both sides walks out of the station with marks.[1][7]

Overview and definition

Gestational diabetes is a statement about detection, not about aetiology. It means hyperglycaemia first found in pregnancy that does not reach the criteria for overt diabetes.[1][16]

  • Some of these women have transient pregnancy-induced glucose intolerance that resolves at birth.
  • Some have pre-existing beta-cell dysfunction that pregnancy has simply unmasked.
  • A few have undiagnosed type 2 diabetes, monogenic diabetes, or early type 1 diabetes wearing a GDM label.[1][16]

That heterogeneity is why the postpartum test matters as much as the antenatal one, and why "her GDM resolved" is never a discharge diagnosis until you have proved it.[1][15]

The word that earns the markSay "hyperglycaemia in pregnancy", then split it: overt diabetes in pregnancy versus gestational diabetes, and early GDM (before 20 weeks) versus GDM diagnosed at 24–28 weeks. Those four labels drive four different management plans.[1]
Obstetrics & Gynaecology Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship library.

Sign in to continueSee pricing
References20ShowHide
  1. [1]Sweeting A, Hare MJ, de Jersey SJ, et al. Australasian Diabetes in Pregnancy Society (ADIPS) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes. Med J Aust, 2025.PMID 40544364
  2. [2]Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med, 2008.PMID 18463375
  3. [3]Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care, 2010.PMID 20190296
  4. [4]Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med, 2005.PMID 15951574
  5. [5]Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med, 2009.PMID 19797280
  6. [6]Simmons D, Immanuel J, Hague WM, et al. Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy. N Engl J Med, 2023.PMID 37144983
  7. [7]Crowther CA, Samuel D, McCowan LME, et al. Lower versus Higher Glycemic Criteria for Diagnosis of Gestational Diabetes. N Engl J Med, 2022.PMID 36070709
  8. [8]Crowther CA, Samuel D, Hughes R, et al. Tighter or less tight glycaemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity: A stepped-wedge, cluster-randomised trial. PLoS Med, 2022.PMID 36074760
  9. [9]Hillier TA, Pedula KL, Ogasawara KK, et al. A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening. N Engl J Med, 2021.PMID 33704936
  10. [10]Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med, 2008.PMID 18463376
  11. [11]Brown J, Martis R, Hughes B, et al. Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes. Cochrane Database Syst Rev, 2017.PMID 28120427
  12. [12]Brown J, Alwan NA, West J, et al. Lifestyle interventions for the treatment of women with gestational diabetes. Cochrane Database Syst Rev, 2017.PMID 28472859
  13. [13]Biesty LM, Egan AM, Dunne F, et al. Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants. Cochrane Database Syst Rev, 2018.PMID 29303230
  14. [14]Committee on Practice Bulletins-Obstetrics ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol, 2018.PMID 29370047
  15. [15]Vounzoulaki E, Khunti K, Abner SC, et al. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ, 2020.PMID 32404325
  16. [16]Sweeting A, Hannah W, Backman H, et al. Epidemiology and management of gestational diabetes. Lancet, 2024.PMID 38909620
  17. [17]Harris DL, Weston PJ, Harding JE Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr, 2012.PMID 22727868
  18. [18]Roberts L, Lin L, Alsweiler J, et al. Oral dextrose gel to prevent hypoglycaemia in at-risk neonates. Cochrane Database Syst Rev, 2023.PMID 38014716
  19. [19]Farrant MT, Williamson K, Battin M, et al. The use of dextrose/insulin infusions during labour and delivery in women with gestational diabetes mellitus: Is there any point? Aust N Z J Obstet Gynaecol, 2017.PMID 27531282
  20. [20]Gordon HG, Shub A, Walker SP, et al. Maternal Diabetes, Fetal Growth, and Stillbirth Risk: A Population-Wide Retrospective Cohort Study From Victoria, Australia. Diabetes Care, 2025.PMID 40902109
Obstetrics & Gynaecology Pro

$29/ monthor $279 / year

The complete Obstetrics & Gynaecology library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousGenetic carrier screeningAntenatal care — genetic screeningNextHypertensive disorders of pregnancy: ISSHP 2021 classification and chronic hypertensionAntenatal care — maternal medicine